Skip to main content

Advertisement

SpringerLink
Log in

Stereotactic ablative radiation therapy for brain metastases with volumetric modulated arc therapy and flattening filter free delivery: feasibility and early clinical results

  • Neuroradiology
  • Published:
La radiologia medica Aims and scope Submit manuscript

Abstract

Aim

For selected patients with brain metastases (BMs), the role of stereotactic radiosurgery (SRS) or fractionated stereotactic radiotherapy (SFRT) is well recognized. The recent introduction of flattening filter free (FFF) delivery during linac-based SRS or SFRT allows shorter beam-on-time, improving patients’ comfort and facility workflow. Nevertheless, limited experiences evaluated the impact of FFF linac-based SRS and SFRT in BMs treatment. Aim of the current study was to analyze SRS/SFRT linac-based FFF delivery for BMs in terms of dosimetric and early clinical results.

Materials and methods

Patients with life expectancy >3 months, number of BMs <5, diameter <3 cm, and controlled or synchronous primary tumor received SRS/SFRT. The prescribed total dose and fractionation, based on BMs size and proximity to organs at risk, ranged from 15 Gy in 1 fraction to 30 Gy in 5 fractions. A FFF volumetric modulated arc therapy (VMAT) plan was generated with one or two coplanar partial arcs. Toxicity was assessed according to CTCAE v4.0.

Results

From April 2014 to February 2016, 45 patients (89 BMs) were treated with SRS/SFRT linac-based FFF delivery. The mean beam-on-time was 140 s for each lesion (range 90–290 s) and the average brain Dmean was 1 Gy (range 0.1–4.8 Gy). At the time of analysis, local control was reported in 93.2% (83/89 BMs). With a median follow-up time of 12 months (range 1–27 months), the median overall survival was 14 months and the 6-month overall survival was 77%. Finally, the median intracranial disease control was 11 months. Acute and late toxicities were acceptable without severe events (no adverse events ≥G2 were recorded).

Conclusions

These preliminary results highlighted the feasibility and safety of linac-based SRS/SFRT with FFF mode for BMs patients. A longer follow-up is necessary to confirm the efficacy of this treatment modality in BM patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Mehta MP, Tsao MN, Whelan TJ et al (2005) The American society for therapeutic radiology and oncology (ASTRO) evidence-based review of the role of radiosurgery for brain metastasis. Int J Radiat Oncol Biol Phys 63:37–46. doi:10.1016/j.ijrobp.2005.05.023

    Article  PubMed  Google Scholar 

  2. Patchell RA (2003) The management of brain metastases. Cancer Treat Rev 29:533–540. doi:10.1016/S0305-7372(03)00105-1

    Article  PubMed  Google Scholar 

  3. Lin X, DeAngelis LM (2015) Treatment of brain metastases. J Clin Oncol 33:3475–3484. doi:10.1200/JCO.2015.60.9503

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. NCCN guide lines (2016) https://www.nccn.org/professionals/physician_gls/f_guidelines.asp. Accessed 30 Oct 2016

  5. Kocher M, Wittig A, Piroth MD et al (2014) Stereotactic radiosurgery for treatment of brain metastases. A report of the DEGRO Working Group on Stereotactic Radiotherapy. Strahlenther Onkol 190:521–532. doi:10.1007/s00066-014-0648-7

    Article  PubMed  Google Scholar 

  6. Soffietti R, Kocher M, Abacioglu UM et al (2013) A European organisation for research and treatment of cancer phase III trial of adjuvant whole-brain radiotherapy versus observation in patients with one to three brain metastases from solid tumors after surgical resection or radiosurgery: quality-of-life result. J Clin Oncol 31:65–72. doi:10.1200/JCO.2011.41.0639

    Article  PubMed  Google Scholar 

  7. Brown PD, Jaeckle K, Ballman KV et al (2016) Effect of radiosurgery alone vs radiosurgery with whole brain radiation therapy on cognitive function in patients with 1 to 3 brain metastases: a randomized clinical trial. JAMA 316:401–409. doi:10.1001/jama.2016.9839

    Article  PubMed  PubMed Central  Google Scholar 

  8. Giaj Levra N, Sicignagno G, Fiorentino A et al (2016) Whole brain radiotherapy with hippocampal avoidance and simultaneous integrated boost for brain metastases: a dosimetric volumetric-modulated arc therapy study. Radiol Med 121:60–69. doi:10.1007/s11547-015-0563-8

    Article  PubMed  Google Scholar 

  9. Nieder C, Grosu AL, Gaspar LE (2014) Stereotactic radiosurgery (SRS) for brain metastases: a systematic review. Radiat Oncol 9:155. doi:10.1186/1748-717X-9-155

    Article  PubMed  PubMed Central  Google Scholar 

  10. Leksell L (1951) The stereotactic method and radiosurgery of the brain. Acta Chir Scand 102:316–319

    CAS  PubMed  Google Scholar 

  11. Wu A, Lindner G, Maitz AH et al (1990) Physics of Gamma Knife approach on convergent beams in stereotactic radiosurgery. Int J Radiat Oncol Biol Phys 18:941–949

    Article  CAS  PubMed  Google Scholar 

  12. Alongi F, Fiorentino A, Mancosu P et al (2016) Stereotactic radiosurgery for intracranial metastases: linac-based and gamma-dedicated unit approach. Expert Rev Anticancer Ther 16:731–740. doi:10.1080/14737140.2016.1190648

    Article  CAS  PubMed  Google Scholar 

  13. Fiorentino A, Levra NG, Mazzola R et al (2015) Letter: volumetric arc therapy (RapidArc) vs Gamma Knife radiosurgery for multiple brain metastases: not only a dosimetric issue. Neurosurgery 77:E310. doi:10.1227/NEU.0000000000000796

    Article  PubMed  Google Scholar 

  14. Fiorentino A, Giaj-Levra N, Mazzola R et al (2015) Dosimetrics of intracranial stereotactic radiosurgery: only “an exercise of style”? Strahlenther Onkol 191:810–811. doi:10.1007/s00066-015-0879-2

    Article  PubMed  Google Scholar 

  15. Abacioglu U, Ozen Z, Yilmaz M et al (2014) Critical appraisal of RapidArc radiosurgery with flattening filter free photon beams for benign brain lesions in comparison to GammaKnife: a treatment planning study. Radiat Oncol 9:119. doi:10.1186/1748-717X-9-119

    Article  PubMed  PubMed Central  Google Scholar 

  16. Kragl G, Sigamani A, Nambiraj A et al (2009) Dosimetric characteristics of 6 and 10 MV unflattened photon beams. Radiother Oncol 93:141–146. doi:10.1016/j.radonc.2009.06.008

    Article  CAS  PubMed  Google Scholar 

  17. Cashmore J (2008) The characterization of unflattened photon beams from a 6 MV linear accelerator. Phys Med Biol 53:1933–1946. doi:10.1088/0031-9155/53/7/009

    Article  PubMed  Google Scholar 

  18. Vassiliev ON, Titt U, Pönisch F et al (2006) Dosimetric properties of photon beams from a flattening filter free clinical accelerator. Phys Med Biol 51:1907–1917

    Article  PubMed  Google Scholar 

  19. Rieber J, Tonndorf-Martini E, Schramm O et al (2016) Radiosurgery with flattening-filter-free techniques in the treatment of brain metastases: plan comparison and early clinical evaluation. Strahlenther Onkol 192:789–796

    Article  CAS  PubMed  Google Scholar 

  20. Lohse I, Lang S, Hrbacek J et al (2011) Effect of high dose per pulse flattening filter-free beams on cancer cell survival. Radiother Oncol 101:226–232. doi:10.1016/j.radonc.2011.05.072

    Article  CAS  PubMed  Google Scholar 

  21. Lai Y, Chen S, Xu C et al (2016) Dosimetric superiority of flattening filter free beams for single-fraction stereotactic radiosurgery in single brain metastasis. Oncotarget 3. doi:10.18632/oncotarget.13085 (Epub ahead of print)

    Google Scholar 

  22. Stieler F, Fleckenstein J, Simeonova A et al (2013) Intensity modulated radiosurgery of brain metastases with flattening filter-free beams. Radiother Oncol 109:448–451. doi:10.1016/j.radonc.2013.10.017

    Article  PubMed  Google Scholar 

  23. Shaw E, Scott C, Souhami L et al (2000) Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05. Int J Radiat Oncol Biol Phys 47:291–298. doi:10.1016/S0360-3016(99)00507-6

    Article  CAS  PubMed  Google Scholar 

  24. Lischalk JW, Oermann E, Collins SP et al (2015) Five-fraction stereotactic radiosurgery (SRS) for single inoperable high-risk non-small cell lung cancer (NSCLC) brain metastases. Radiat Oncol. 10:216. doi:10.1186/s13014-015-0525-2

    Article  PubMed  PubMed Central  Google Scholar 

  25. van Persijn van Meerten EL, Gelderblom H, Bloem JL (2010) RECIST revised: implications for the radiologist. A review article on the modified RECIST guideline. Eur Radiol 20:1456–1467. doi:10.1007/s00330-009-1685-y

    Article  Google Scholar 

  26. Kumar AJ, Leeds NE, Fuller GN et al (2000) Malignant gliomas: MR imaging spectrum of radiation therapy- and chemotherapy-induced necrosis of the brain after treatment. Radiology 217:377–384

    Article  CAS  PubMed  Google Scholar 

  27. Koay E, Sulman EP (2012) Management of brain metastasis: past lessons, modern management, and future considerations. Curr Oncol Rep. 14:70–78. doi:10.1007/s11912-011-0205-9

    Article  PubMed  Google Scholar 

  28. Maclean J, Fersht N, Singhera M et al (2013) Multi-disciplinary management for patients with oligometastases to the brain: results of a 5 year cohort study. Radiat Oncol 8:156. doi:10.1186/1748-717X-8-156

    Article  PubMed  PubMed Central  Google Scholar 

  29. D’Agostino GR, Autorino R, Pompucci A et al (2011) Whole-brain radiotherapy combined with surgery or stereotactic radiotherapy in patients with brain oligometastases: long-term analysis. Strahlenther Onkol 187:421–425. doi:10.1007/s00066-011-2228-4

    Article  PubMed  Google Scholar 

  30. Balducci M, Autorino R, Chiesa S et al (2015) Radiosurgery or fractionated stereotactic radiotherapy plus whole-brain radioherapy in brain oligometastases: a long-term analysis. Anticancer Res 35:3055–3059

    PubMed  Google Scholar 

  31. Yamamoto M, Serizawa T, Shuto T et al (2014) Stereotactic radiosurgery for patients with multiple brain metastases (JLGK0901): a multi-institutional prospective observational study. Lancet Oncol 15:387–395. doi:10.1016/S1470-2045(14)70061-0

    Article  PubMed  Google Scholar 

  32. Minniti G, Scaringi C, Paolini S et al (2016) Single-fraction versus multifraction (3 × 9 Gy) stereotactic radiosurgery for large (>2 cm) brain metastases: a comparative analysis of local control and risk of radiation-induced brain necrosis. Int J Radiat Oncol Biol Phys 95:1142–1148. doi:10.1016/j.ijrobp.2016.03.013

    Article  PubMed  Google Scholar 

  33. Croker J, Chua B, Bernard A et al (2016) Treatment of brain oligometastases with hypofractionated stereotactic radiotherapy utilising volumetric modulated arc therapy. Clin Exp Metastasis 33:125–132. doi:10.1007/s10585-015-9762-x

    Article  CAS  PubMed  Google Scholar 

  34. King RB, Hyland WB, Cole AJ et al (2013) An in vitro study of the radiobiological effects of flattening filter free radiotherapy treatments. Phys Med Biol 58(5):N83–N94. doi:10.1088/0031-9155/58/5/N83

    Article  CAS  PubMed  Google Scholar 

  35. Franco P, De Bari B, Ciammella P et al (2014) The role of stereotactic ablative radiotherapy in oncological and non-oncological clinical settings: highlights from the 7th meeting of AIRO–Young Members Working Group (AIRO Giovani). Tumori 100:e214–e219. doi:10.1700/1778.19280

    PubMed  Google Scholar 

  36. Navarria P, Ascolese AM, Mancosu P et al (2013) Volumetric modulated arc therapy with flattening filter free (FFF) beams for stereotactic body radiation therapy (SBRT) in patients with medically inoperable early stage non small cell lung cancer (NSCLC). Radiother Oncol 107:414–418. doi:10.1016/j.radonc.2013.04.016

    Article  PubMed  Google Scholar 

  37. Reggiori G, Mancosu P, Castiglioni S et al (2012) Can volumetric modulated arc therapy with flattening filter free beams play a role in stereotactic body radiotherapy for liver lesions? A volume-based analysis. Med Phys 39:1112–1118. doi:10.1118/1.3679858

    Article  PubMed  Google Scholar 

  38. Zwahlen DR, Lang S, Hrbacek J et al (2012) The use of photon beams of a flattening filter-free linear accelerator for hypofractionated volumetric modulated arc therapy in localized prostate cancer. Int J Radiat Oncol Biol Phys 83:1655–1660. doi:10.1016/j.ijrobp.2011.10.019

    Article  PubMed  Google Scholar 

  39. Zhuang M, Zhang T, Chen Z et al (2012) Volumetric modulation arc radiotherapy with flattening filter-free beams compared with conventional beams for nasopharyngeal carcinoma: a feasibility study. Chin J Cancer 32:397–402. doi:10.5732/cjc.012.10182

    Article  PubMed  Google Scholar 

  40. Lechner W, Kragl G, Georg D (2012) Evaluation of treatment plan quality of IMRT and VMAT with and without flattening filter using Pareto optimal fronts. Radiother Oncol 103:97. doi:10.1016/j.radonc.2013.09.020

    Article  Google Scholar 

  41. Lang S, Shrestha B, Graydon S et al (2013) Clinical application of flattening filter free beams for extracranial stereotactic radiotherapy. Radiother Oncol 106:255–259. doi:10.1016/j.radonc.2012.12.012

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Radiation Oncology, Sacro Cuore Don Calabria Cancer Care Center, Via Don Sempreboni 5, Negrar, 37034, Verona, Italy

    Alba Fiorentino, Niccolò Giaj-Levra, Umberto Tebano, Rosario Mazzola, Francesco Ricchetti, Sergio Fersino, Dario Aiello, Ruggero Ruggieri & Filippo Alongi

  2. Statistic Science Faculty, University of Palermo, Palermo, Italy

    Gioacchino Di Paola

Authors
  1. Alba Fiorentino
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Niccolò Giaj-Levra
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Umberto Tebano
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Rosario Mazzola
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Francesco Ricchetti
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Sergio Fersino
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Gioacchino Di Paola
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Dario Aiello
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Ruggero Ruggieri
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Filippo Alongi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Niccolò Giaj-Levra.

Ethics declarations

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Conflict of interest

The authors declare that they have no conflict of interest. Informed consent was obtained from all individual participants included in the study.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fiorentino, A., Giaj-Levra, N., Tebano, U. et al. Stereotactic ablative radiation therapy for brain metastases with volumetric modulated arc therapy and flattening filter free delivery: feasibility and early clinical results. Radiol med 122, 676–682 (2017). https://doi.org/10.1007/s11547-017-0768-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11547-017-0768-0

Keywords

Search

Navigation